Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Acyclic nitrogen double bonded to acyclic nitrogen – acyclic...
Reexamination Certificate
2011-06-07
2011-06-07
Powers, Fiona T (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Acyclic nitrogen double bonded to acyclic nitrogen, acyclic...
C514S404000, C534S792000, C548S367400
Reexamination Certificate
active
07956048
ABSTRACT:
New polymorphs of Eltrombopag and Eltrombopag ethanolamine salt have been obtained and characterized. These polymorphs and pharmaceutical compositions comprising them are useful, for example, in treating conditions leading to thrombocytopenia.
REFERENCES:
patent: 7160870 (2007-01-01), Duffy et al.
patent: 7332481 (2008-02-01), Duffy et al.
patent: 7547719 (2009-06-01), Moore
patent: 7795293 (2010-09-01), Moore
patent: 2004/0019190 (2004-01-01), Erickson-Miller et al.
patent: 2006/0178518 (2006-08-01), Moore
patent: 1 294 378 (2007-10-01), None
patent: WO 01/89457 (2001-11-01), None
patent: WO 03/098992 (2003-12-01), None
M.R. Caira “Crystalline Polymorphism of Organic Compounds” Topics in Current Chemistry, vol. 198, p. 163-208, (1998) XP001156954.
Antonac Irena Zrinski
Ceric Helena
Leksic Edislav
Mundorfer Tina
Samardzic Zrinka Mastelic
Merchant & Gould P,C,
Pliva Hrvatska D.O.O.
Powers Fiona T
LandOfFree
Polymorphs of eltrombopag and eltrombopag salts and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymorphs of eltrombopag and eltrombopag salts and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymorphs of eltrombopag and eltrombopag salts and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2720439